Left Cardiac Sympathetic Denervation in the Management of High-Risk Patients Affected by the Long-QT Syndrome

Circulation

Volumn 109, Issue 15, 2004, Pages 1826-1833

  Schwartz, Peter J ^a,b   Priori, Silvia G ^a,c   Cerrone, Marina ^a,b   Spazzolini, Carla ^b   Odero, Attilio ^a,b   Napolitano, Carlo ^c   Bloise, Raffaella ^c   De Ferrari, Gaetano M ^b   Klersy, Catherine ^b   Moss, Arthur J ^d   Zareba, Wojciech ^d   Robinson, Jennifer L ^d   Hall, W Jackson ^d   Brink, Paul A ^f   Toivonen, Lauri ^g   Epstein, Andrew E ^e   Li, Cuilan ^h   Hu, Dayi ^h  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c IRCCS   (Italy)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e University of Alabama at Birmingham   (United States)

^f STELLENBOSCH UNIVERSITY   (South Africa)

^g UNIVERSITY OF HELSINKI   (Finland)

^h PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Death, sudden; Genetics; Long QT syndrome; Nervous system, sympathetic

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADOLESCENT; ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; AUTONOMIC DENERVATION; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; GENOTYPE; HEART ARREST; HIGH RISK POPULATION; HUMAN; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QT INTERVAL; SUDDEN DEATH; SYNCOPE;

ADOLESCENT; ADULT; CHILD; ELECTROCARDIOGRAPHY; FOLLOW-UP STUDIES; GANGLIONECTOMY; GENOTYPE; HEART; HUMANS; LONG QT SYNDROME; MALE; RISK FACTORS; SYMPATHECTOMY;

EID: 11144356780     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000125523.14403.1E     Document Type: Article

References (24)

1. Schwartz PJ, Priori SG, Napolitano C. The long QT syndrome. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. 3rd ed. Philadelphia, Pa: WB Saunders Co; 2000:597-615.
2. Schwartz PJ. Idiopathic long QT syndrome: progress and questions. Am Heart J. 1985;109:399-411.
3. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103:89-95.
4. Schwartz PJ. Another role for the sympathetic nervous system in the long QT syndrome? J Cardiovasc Electrophysiol. 2001;12:500-502.
5. Moss AJ, Zareba W, Hall WJ, et al. Effectiveness and limitations of β-blocker therapy in congenital long QT syndrome. Circulation. 2000; 101:616-623.
6. Priori SG, Aliot E, Blomstrom-Lundqvist C, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J. 2001;22:1374-1450.
7. Schwartz PJ. The rationale and the role of left stellectomy for the prevention of malignant arrhythmias. Ann N Y Acad Sci. 1984;427:199-221.
8. Schwartz PJ, Snebold NG, Brown AM. Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. Am J Cardiol. 1976;37:1034-1040.
9. Moss AJ, McDonald J. Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome. N Engl J Med. 1971;285:903-904.
10. Schwartz PJ, Locati EH, Moss AJ, et al. Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome: a worldwide report. Circulation. 1991;84:503-511.
11. Schwartz PJ, Periti M, Malliani A. The long QT syndrome. Am Heart J. 1975;89:378-390.
12. Ouriel K, Moss AJ, Long QT syndrome: an indication for cervicothoracic sympathectomy. Cardiovasc Surg. 1995;3:475-478.
13. Bhandari AK, Scheinman MM, Morady F, et al. Efficacy of left cardiac sympathectomy in the treatment of patients with the long QT syndrome. Circulation. 1984;70:1018-1023.
14. Schwartz PJ, Moss AJ, Vincent GM, et al. Diagnostic criteria for the long QT syndrome: an update. Circulation. 1993;88:782-784.
15. Schwartz PJ, Priori SG, Napolitano C. How really rare are rare diseases? The intriguing case of independent compound mutations in the long QT syndrome. J Cardiovasc Electrophysiol 2003;14:1120-1121.
16. Zareba W, Moss AJ, Daubert JP, et al. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol. 2003;14:337-341.
17. Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med. 2003;348:1866-1874.
18. Yanowitz F, Preston JB, Abildskov JA. Functional distribution of right and left stellate innervation to the ventricles: production of neurogenic electrocardiographic changes by unilateral alteration of sympathetic tone. Circ Res. 1966;18:416-428.
19. Schwartz PJ, Priori SG: Sympathetic nervous system and cardiac arrhythmias. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pa: WB Saunders Co; 1990:330-343.
20. Cao JM, Chen LS, KenKnight BH, et al. Nerve sprouting and sudden cardiac death. Circ Res. 2000;86:816-821.
21. Schwartz PJ. QT prolongation, sudden death, and sympathetic imbalance: the pendulum swings. J Cardiovasc Electrophysiol. 2001;12:1074-1077.
22. Schwartz PJ, Motolese M, Pollavini G, et al. Prevention of sudden cardiac death after a first myocardial infarction by pharmacologic or surgical antiadrenergic interventions. J Cardiovasc Electrophysiol. 1992;3:2-16.
23. Schwartz PJ, Stone HL. Effects of unilateral stellectomy upon cardiac performance during exercise in dogs. Circ Res. 1979;44:637-645.
24. + channel blockade and to increases in heart rate: implications for gene-specific therapy. Circulation. 1995;92:3381-3386.